Company intelligence / Profile preview

Laconia Capital Group

New York, New York, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Laconia Capital Group is a New York-based venture capital firm focused primarily on pre-seed and seed-stage B2B software companies. The firm invests across sectors such as enterprise software, fintech, ecommerce, martech, infrastructure, supply chain technology, and selected health tech opportunities rather than operating as a drug developer or healthcare services company. Laconia describes itself as dedicated to seed investing and hands-on support for founders, with a portfolio spanning the United States and Canada. Based on publicly available information, it is not a biotech, pharma, or broader life sciences operating company and does not appear to maintain a therapeutic pipeline.

Industry: Investors

Beyond the preview

Go deeper on Laconia Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laconia Capital Group.

Explore the full profile